As part of its #MeetTheNeed initiative, General Atlantic today announced the updated the efforts of its portfolio company, Ginkgo Bioworks, in developing large-scale COVID-19 testing. Ginkgo is a biotech company within the Life Sciences sector of General Atlantic.
General Atlantic launched its #MeetTheNeed initiative in May of 2020. Through #MeetTheNeed, General Atlantic collects and shares the stories of its portfolio companies. Specifically, the stories cover the way portfolio companies have mobilized in response to COVID-19.
COVID-19 and Ginkgo Bioworks
At the start of the COVID-19 pandemic, Ginkgo made a commitment to use the scale of its facilities to help combat the virus. Subsequently, Ginkgo opened its platform with $25 million of free foundry work that any qualified com…